|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.7843 USD | +4.88% |
|
+11.09% | -59.36% |
| 08-31 | Daré Bioscience Receives New NIH Funding Award Of Approximately USD 908,000 To Advance DARE-PTB2 For The Prevention Of Preterm Birth | CI |
| 08-26 | Daré Bioscience, Inc. - Special Call |
| Market Cap | 11.99M 10.46M 9.87M 8.97M 16.8M 1.15B 16.87M 118M 45.64M 585M 45.05M 44.05M 1.88B | P/E 2026 * |
-1.01x | P/E 2027 * | -1.89x |
|---|---|---|---|---|---|
| Enterprise Value | 11.99M 10.46M 9.87M 8.97M 16.8M 1.15B 16.87M 118M 45.64M 585M 45.05M 44.05M 1.88B | EV / Sales 2026 * |
4.41x | EV / Sales 2027 * | 1.35x |
| Free-Float |
87.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DARE | Delayed | |
CBOE
| DARE | Real-time |
Last Transcript: Daré Bioscience, Inc.
| 1 day | +4.88% | ||
| 1 week | +11.09% | ||
| Current month | +3.06% | ||
| 1 month | +2.10% | ||
| 3 months | -63.86% | ||
| 6 months | -43.98% | ||
| Current year | -59.36% |
| 1 week | 0.69 |  | 0.81 |
| 1 month | 0.69 | | 0.86 |
| Current year | 0.69 | | 3.78 |
| 1 year | 0.69 | | 3.78 |
| 3 years | 0.69 | | 9.19 |
| 5 years | 0.69 | | 30.12 |
| 10 years | 0.69 | | 79.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sabrina Johnson
CEO | Chief Executive Officer | 59 | 2017-06-30 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 59 | 2017-06-30 |
Susan Kelley
BRD | Director/Board Member | 71 | 2014-09-30 |
| Chairman | 78 | 2019-07-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/26 | Free | Director | 30,805 | 0.2056% | ||
| 6/30/26 | Free | Director | 26,540 | 0.1772% | ||
| 6/30/26 | Free | Director | 23,696 | 0.1582% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.88% | +11.09% | -62.29% | -86.24% | 11.99M | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.67% | +4.04% | +17.30% | +32.15% | 360.17B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.15% | +61.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.72M 2.37M 2.24M 2.03M 3.81M 261M 3.82M 26.8M 10.34M 133M 10.21M 9.98M 427M | 8.86M 7.73M 7.3M 6.63M 12.42M 850M 12.47M 87.42M 33.73M 432M 33.3M 32.56M 1.39B |
| Net income | -12.99M -11.33M -10.69M -9.71M -18.19M -1.25B -18.27M -128M -49.43M -634M -48.79M -47.7M -2.04B | -12.07M -10.53M -9.94M -9.02M -16.91M -1.16B -16.98M -119M -45.94M -589M -45.34M -44.33M -1.89B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$0.7843 | +4.88% | 229,162 |
| 26-09-17 | US$0.7478 | +3.07% | 153,927 |
| 26-09-16 | US$0.7255 | -0.63% | 135,502 |
| 26-09-15 | US$0.7301 | -0.84% | 109,230 |
| 26-09-14 | US$0.7363 | +4.29% | 426,367 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DARE Stock
Select your edition
All financial news and data tailored to specific country editions
